Beam Therapeutics IncNASDAQ:BEAM
- LAST PRICE30.2850
- TODAY'S CHANGE (%)-1.3550 (-4.2826%)
- Bid / Lots30.2700/ 2
- Ask / Lots30.3000/ 3
- Open / Previous Close31.1200 / 31.6400
- Day Range
- 52 Week Range
- Volume954,089
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BEAM |
|---|---|---|
| 09:32 ET | 11193 | 31.25 |
| 09:34 ET | 7804 | 30.77 |
| 09:36 ET | 1120 | 30.9615 |
| 09:38 ET | 5279 | 31.22 |
| 09:39 ET | 3306 | 31.26 |
| 09:41 ET | 2436 | 31.29 |
| 09:43 ET | 6863 | 31.4 |
| 09:45 ET | 1821 | 31.61 |
| 09:48 ET | 1677 | 31.43 |
| 09:50 ET | 2140 | 31.625 |
| 09:52 ET | 4335 | 31.3 |
| 09:54 ET | 4353 | 31.435 |
| 09:56 ET | 1750 | 31.35 |
| 09:57 ET | 6602 | 31.36 |
| 09:59 ET | 4188 | 31.43 |
| 10:01 ET | 3835 | 31.35 |
| 10:03 ET | 4085 | 31.495 |
| 10:06 ET | 4103 | 31.355 |
| 10:08 ET | 4162 | 31.26 |
| 10:10 ET | 7237 | 31.2 |
| 10:12 ET | 2222 | 31.21 |
| 10:14 ET | 4732 | 31.01 |
| 10:15 ET | 3857 | 30.8996 |
| 10:17 ET | 5600 | 30.9 |
| 10:19 ET | 2512 | 30.88 |
| 10:21 ET | 3365 | 30.81 |
| 10:24 ET | 1982 | 30.7963 |
| 10:26 ET | 2150 | 30.855 |
| 10:28 ET | 5424 | 30.795 |
| 10:30 ET | 4494 | 30.68 |
| 10:32 ET | 2856 | 30.67 |
| 10:33 ET | 7452 | 30.45 |
| 10:35 ET | 6582 | 30.5901 |
| 10:37 ET | 4328 | 30.25 |
| 10:39 ET | 7308 | 30.335 |
| 10:42 ET | 2797 | 30.28 |
| 10:44 ET | 5300 | 30.19 |
| 10:46 ET | 2604 | 30.2 |
| 10:48 ET | 2027 | 30.32 |
| 10:50 ET | 1962 | 30.105 |
| 10:51 ET | 2547 | 30.23 |
| 10:53 ET | 10218 | 30.04 |
| 10:55 ET | 3197 | 30.24 |
| 10:57 ET | 1385 | 30.16 |
| 11:00 ET | 2100 | 30.15 |
| 11:02 ET | 1900 | 30.1 |
| 11:04 ET | 900 | 30.08 |
| 11:06 ET | 3141 | 30.035 |
| 11:08 ET | 9669 | 30.01 |
| 11:09 ET | 320 | 30.025 |
| 11:11 ET | 3036 | 30.05 |
| 11:13 ET | 4312 | 29.995 |
| 11:15 ET | 3475 | 30 |
| 11:18 ET | 1537 | 30.06 |
| 11:20 ET | 3060 | 30.035 |
| 11:22 ET | 2500 | 30.075 |
| 11:24 ET | 20563 | 30 |
| 11:26 ET | 6128 | 29.885 |
| 11:27 ET | 39559 | 29.975 |
| 11:29 ET | 83017 | 29.93 |
| 11:31 ET | 2383 | 29.92 |
| 11:33 ET | 2427 | 29.85 |
| 11:36 ET | 10433 | 29.86 |
| 11:38 ET | 29881 | 29.96 |
| 11:40 ET | 32584 | 30.06 |
| 11:42 ET | 21188 | 30.04 |
| 11:44 ET | 2013 | 29.97 |
| 11:45 ET | 942 | 30.03 |
| 11:47 ET | 7678 | 30 |
| 11:49 ET | 4445 | 30 |
| 11:51 ET | 3927 | 30.0248 |
| 11:54 ET | 4690 | 30.15 |
| 11:56 ET | 548 | 30.2 |
| 11:58 ET | 1700 | 30.25 |
| 12:00 ET | 549 | 30.245 |
| 12:02 ET | 1617 | 30.29 |
| 12:03 ET | 1700 | 30.26 |
| 12:05 ET | 1700 | 30.345 |
| 12:07 ET | 1000 | 30.34 |
| 12:09 ET | 1140 | 30.35 |
| 12:12 ET | 527 | 30.37 |
| 12:14 ET | 1335 | 30.34 |
| 12:16 ET | 1300 | 30.36 |
| 12:18 ET | 5240 | 30.5 |
| 12:20 ET | 1933 | 30.53 |
| 12:21 ET | 4819 | 30.51 |
| 12:23 ET | 1124 | 30.42 |
| 12:25 ET | 900 | 30.47 |
| 12:27 ET | 1194 | 30.505 |
| 12:30 ET | 1792 | 30.5466 |
| 12:32 ET | 2483 | 30.58 |
| 12:34 ET | 600 | 30.605 |
| 12:36 ET | 700 | 30.56 |
| 12:38 ET | 2756 | 30.58 |
| 12:39 ET | 1900 | 30.5 |
| 12:41 ET | 4527 | 30.54 |
| 12:43 ET | 2793 | 30.47 |
| 12:45 ET | 748 | 30.5 |
| 12:48 ET | 1823 | 30.555 |
| 12:50 ET | 400 | 30.59 |
| 12:52 ET | 2672 | 30.5 |
| 12:54 ET | 1593 | 30.445 |
| 12:56 ET | 200 | 30.46 |
| 12:57 ET | 2745 | 30.54 |
| 12:59 ET | 600 | 30.58 |
| 01:01 ET | 1500 | 30.63 |
| 01:03 ET | 2550 | 30.59 |
| 01:06 ET | 1413 | 30.65 |
| 01:08 ET | 7755 | 30.47 |
| 01:10 ET | 700 | 30.48 |
| 01:12 ET | 258 | 30.44 |
| 01:14 ET | 1136 | 30.51 |
| 01:15 ET | 3355 | 30.39 |
| 01:17 ET | 700 | 30.42 |
| 01:19 ET | 1100 | 30.48 |
| 01:21 ET | 2039 | 30.41 |
| 01:24 ET | 610 | 30.38 |
| 01:26 ET | 1367 | 30.37 |
| 01:28 ET | 4635 | 30.21 |
| 01:30 ET | 400 | 30.25 |
| 01:32 ET | 649 | 30.2 |
| 01:33 ET | 2100 | 30.24 |
| 01:35 ET | 800 | 30.2 |
| 01:37 ET | 800 | 30.175 |
| 01:39 ET | 1000 | 30.24 |
| 01:42 ET | 1251 | 30.2011 |
| 01:44 ET | 500 | 30.21 |
| 01:46 ET | 1396 | 30.15 |
| 01:48 ET | 200 | 30.165 |
| 01:50 ET | 2500 | 30.15 |
| 01:51 ET | 875 | 30.14 |
| 01:53 ET | 557 | 30.22 |
| 01:55 ET | 1685 | 30.315 |
| 01:57 ET | 1190 | 30.25 |
| 02:00 ET | 519 | 30.27 |
| 02:02 ET | 2137 | 30.28 |
| 02:04 ET | 300 | 30.27 |
| 02:06 ET | 2405 | 30.29 |
| 02:08 ET | 727 | 30.325 |
| 02:09 ET | 9537 | 30.21 |
| 02:11 ET | 1452 | 30.17 |
| 02:13 ET | 1067 | 30.17 |
| 02:15 ET | 100 | 30.175 |
| 02:18 ET | 2638 | 30.19 |
| 02:20 ET | 434 | 30.18 |
| 02:22 ET | 1200 | 30.16 |
| 02:24 ET | 1070 | 30.1959 |
| 02:26 ET | 401 | 30.16 |
| 02:27 ET | 1000 | 30.17 |
| 02:29 ET | 405 | 30.15 |
| 02:31 ET | 3057 | 30.11 |
| 02:33 ET | 700 | 30.09 |
| 02:36 ET | 1500 | 30.048 |
| 02:38 ET | 4351 | 30.04 |
| 02:40 ET | 4000 | 30.1 |
| 02:42 ET | 200 | 30.13 |
| 02:44 ET | 19802 | 30.05 |
| 02:45 ET | 7185 | 30.02 |
| 02:47 ET | 6847 | 30 |
| 02:49 ET | 3205 | 30.02 |
| 02:51 ET | 1200 | 30.1 |
| 02:54 ET | 554 | 30.05 |
| 02:56 ET | 1225 | 30 |
| 02:58 ET | 900 | 30.04 |
| 03:00 ET | 1300 | 30.05 |
| 03:02 ET | 2300 | 30.12 |
| 03:03 ET | 3922 | 30.25 |
| 03:05 ET | 2874 | 30.29 |
| 03:07 ET | 1947 | 30.26 |
| 03:09 ET | 2012 | 30.19 |
| 03:12 ET | 1147 | 30.21 |
| 03:14 ET | 1240 | 30.27 |
| 03:16 ET | 1696 | 30.27 |
| 03:18 ET | 1022 | 30.23 |
| 03:20 ET | 700 | 30.26 |
| 03:21 ET | 9052 | 30.22 |
| 03:23 ET | 4929 | 30.345 |
| 03:25 ET | 1865 | 30.34 |
| 03:27 ET | 2970 | 30.4 |
| 03:30 ET | 1642 | 30.31 |
| 03:32 ET | 2053 | 30.33 |
| 03:34 ET | 1816 | 30.34 |
| 03:36 ET | 2280 | 30.31 |
| 03:38 ET | 2633 | 30.28 |
| 03:39 ET | 1200 | 30.34 |
| 03:41 ET | 2755 | 30.285 |
Jul 23, 2024
DJ Beam Therapeutics Initiated at Buy by HC Wainwright & Co., from 7:24AM ET on Tuesday Jul 23, 2024 by Dow Jones
7:24AM ET on Tuesday Jul 23, 2024 by Dow Jones
Jul 15, 2024
DJ Beam Therapeutics Shares Fall After News of CFO Departure, from 1:16PM ET on Monday Jul 15, 2024 by Dow Jones
1:16PM ET on Monday Jul 15, 2024 by Dow JonesDJ Beam Therapeutics CFO to Step Down, from 6:43AM ET on Monday Jul 15, 2024 by Dow Jones
6:43AM ET on Monday Jul 15, 2024 by Dow JonesBeam Therapeutics Announces Transition of Chief Financial Officer, from 6:30AM ET on Monday Jul 15, 2024 by Dow Jones
6:30AM ET on Monday Jul 15, 2024 by Dow JonesPress Release: Beam Therapeutics Announces Transition of Chief Financial Officer, from 6:30AM ET on Monday Jul 15, 2024 by Dow Jones
6:30AM ET on Monday Jul 15, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Beam Therapeutics Inc | 2.6B | -17.4x | --- |
Genmab A/S | 18.8B | 23.7x | +22.71% |
Amicus Therapeutics Inc | 3.0B | -20.8x | --- |
Catalyst Pharmaceuticals Inc | 2.0B | 31.4x | --- |
Maravai LifeSciences Holdings Inc | 2.4B | -9.8x | --- |
Veracyte Inc | 1.8B | -24.3x | --- |
Company Information
Beam Therapeutics Inc. is a biotechnology company developing precision genetic medicines through base editing. The Company's suite of gene editing technologies is anchored by base editing, a technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the deoxyribonucleic acid. Its lead programs are focused on sickle cell disease and alpha-1 antitrypsin deficiency, and it is also advancing programs in other genetic diseases, as well as immunology/oncology. Its primary programs include BEAM-101, Engineered Stem Cell Antibody Paired Evasion (ESCAPE), BEAM-302, BEAM-301 and BEAM-201. BEAM-101 is a patient-specific, autologous hematopoietic stem cell (HSC), investigational therapy. ESCAPE is a potentially non-genotoxic approach to HSC transplantation. BEAM-302 is a liver-targeting lipid nanoparticle formulation of base editing reagents. BEAM-201 is an anti-CD7 CAR-T product candidate.
Contact Information
- Headquarters
- 238 Main StreetCAMBRIDGE, MA, United States 02142
- Phone
- 857-327-8775
- Fax
- 302-655-5049
Executives
- President
- Giuseppe Ciaramella
- Chief Executive Officer, Principal Financial and Accounting Officer, Director
- John Evans
- Chief Financial Officer, Treasurer
- Terry-Ann Burrell
- Chief Medical Officer
- Amy Simon
- Chief Legal Officer and Secretary
- Christine Bellon
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.6B |
|---|---|
Revenue (TTM) | $360.9M |
Shares Outstanding | 82.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.87 |
EPS | $-1.74 |
Book Value | $12.02 |
P/E Ratio | -17.4x |
Price/Sales (TTM) | 7.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -50.34% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
